Drugs & Targets Novartis’s Kymriah becomes first gene therapy to get FDA approval October 03, 2017Vol.40 No.08
Study of 15,000 mammograms shows pressure guided mammography may improve test results October 03, 2017Vol.40 No.08
Large study finds that women have superior response to esophageal cancer treatment October 03, 2017Vol.40 No.08
Kura Oncology announces positive phase II study for Tipifarnib in HRAS mutant disease October 03, 2017Vol.40 No.08
Randomized data from CMB305 + checkpoint inhibitor study show clinical benefit and immune response October 03, 2017Vol.40 No.08
